Drugmaker Amag Under Pressure From Activist Investors
Camber Capital Management on Friday became the second activist investor this month to seek a shake-up at Amag Pharmaceuticals Inc., saying in a securities filing that the Massachusetts-based drugmaker's stock is...To view the full article, register now.
Already a subscriber? Click here to view full article